Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells
- PMID: 16606366
- DOI: 10.1111/j.1471-4159.2006.03803.x
Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells
Abstract
Mutations in alpha-synuclein cause some cases of familial Parkinson's disease (PD), but the mechanism by which alpha-synuclein promotes degeneration of dopamine-producing neurons is unknown. We report that human neural cells expressing mutant alpha-synuclein (A30P and A53T) have higher plasma membrane ion permeability. The higher ion permeability caused by mutant alpha-synuclein would be because of relatively large pores through which most cations can pass non-selectively. Both the basal level of [Ca2+]i and the Ca2+ response to membrane depolarization are greater in cells expressing mutant alpha-synuclein. The membrane permeable Ca2+ chelator BAPTA-AM significantly protected the cells against oxidative stress, whereas neither L-type (nifedipine) nor N-type (omega-conotoxin-GVIA) Ca2+ channel blockers protected the cells. These findings suggest that the high membrane ion permeability caused by mutant alpha-synuclein may contribute to the degeneration of neurons in PD.
Similar articles
-
Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.Neurochem Int. 2006 Apr;48(5):329-40. doi: 10.1016/j.neuint.2005.11.008. Epub 2006 Jan 6. Neurochem Int. 2006. PMID: 16406146
-
Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine.Biochemistry. 2004 May 11;43(18):5539-50. doi: 10.1021/bi036114f. Biochemistry. 2004. PMID: 15122920
-
Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity.Hum Mol Genet. 2005 Dec 15;14(24):3801-11. doi: 10.1093/hmg/ddi396. Epub 2005 Oct 20. Hum Mol Genet. 2005. PMID: 16239241
-
Controlling the mass action of alpha-synuclein in Parkinson's disease.J Neurochem. 2008 Oct;107(2):303-16. doi: 10.1111/j.1471-4159.2008.05612.x. Epub 2008 Sep 2. J Neurochem. 2008. PMID: 18691382 Review.
-
Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.Neuron. 2006 Oct 5;52(1):33-8. doi: 10.1016/j.neuron.2006.09.026. Neuron. 2006. PMID: 17015225 Review.
Cited by
-
Mechanisms of neuronal death in synucleinopathy.J Biomed Biotechnol. 2006;2006(3):19365. doi: 10.1155/JBB/2006/19365. J Biomed Biotechnol. 2006. PMID: 17047300 Free PMC article.
-
Parkinson's disease, cortical dysfunction, and alpha-synuclein.Mov Disord. 2011 Jul;26(8):1436-42. doi: 10.1002/mds.23697. Epub 2011 May 3. Mov Disord. 2011. PMID: 21542019 Free PMC article.
-
Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux.J Neurochem. 2009 Mar;108(6):1561-74. doi: 10.1111/j.1471-4159.2009.05932.x. Epub 2009 Jan 24. J Neurochem. 2009. PMID: 19166511 Free PMC article.
-
Neurons and Glia Interplay in α-Synucleinopathies.Int J Mol Sci. 2021 May 8;22(9):4994. doi: 10.3390/ijms22094994. Int J Mol Sci. 2021. PMID: 34066733 Free PMC article. Review.
-
alpha-Synuclein and neuronal cell death.Mol Neurodegener. 2009 Feb 4;4:9. doi: 10.1186/1750-1326-4-9. Mol Neurodegener. 2009. PMID: 19193223 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous